Bugitinib Combined With Venetoclax and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia
Abroad (travel likely)RecruitingPHASE2
Conditions
Acute Myeloid Leukemia · Relapse/Recurrence
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Shenzhen University general hospital, Shenzhen, Guangdong, China
Study leads
Shujiao He, Dr
Principal Investigator
Shenzhen University